CalcMyPeptide
Immune & ThymicAlso known as: Glu-Trp, EW dipeptide, α-glutamyl-tryptophan

Thymogen

Thymogen (Glu-Trp) is a radically effective synthetic dipeptide commanding intense thymopoietic activity. A foundational cornerstone of Eastern European immune medicine, it is clinically deployed to rapidly reconstruct destroyed immune systems post-radiation, completely reverse medication-induced immunosuppression, and crush stubborn, entrenched chronic viral infections. Its microscopic size grants it immediate, devastating efficacy when administered intranasally or subcutaneously.

Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Low1 peer-reviewed citation

Quick Stats

Half-LifeShort (dipeptide)
Dose Range100-1000 mcg/day (intranasal or SC)
Frequency1× daily for 3-10 days
Vial Sizes1 mg, 5 mg
BioavailabilitySublingual or subcutaneous injection
Year Developed1980s

Scientific Data

Molecular Formula
C16H19N3O5
Molecular Weight
337.34 g/mol
CAS Number
PubChem ID

Mechanism of Action

Thymogen (Glu-Trp) is a synthetic dipeptide thymic bioregulator developed by Vladimir Khavinson. It restores T-cell differentiation, NK cell activity, and immune-endocrine balance. Clinical studies show improved immune response in elderly patients and reduced immune senescence markers.

Source: PMID: 15677927

Background & History

Thymogen (Glu-Trp, EW dipeptide) was developed at the Institute of Bioregulation and Gerontology in St. Petersburg as part of Professor Khavinson's peptide bioregulator program. It is distinguished from most bioregulators by its approval status — Thymogen is registered as a pharmaceutical product in the Russian Federation (registration number P N000313/01) and available as both an intranasal spray (25 mcg/dose, OTC) and injection (100 mcg/mL, prescription). It is one of the most widely used thymic immunomodulators in Russian clinical practice.

Research Use Cases

  • Secondary immunodeficiency (post-infection, post-surgery)
  • Chronic bacterial and viral infection adjunct
  • Post-radiation immune recovery
  • Seasonal immune support (cold/flu prevention)

Dosing Protocol

Typical Dose100-1000 mcg/day (intranasal or SC)
Frequency1× daily for 3-10 days
Half-Life~20-30 minutes
Common Vial Sizes1 mg, 5 mg

Dosing Protocols

Khavinson Protocol

Dose
10 - 20 mg
Frequency
Daily SubQ for 10 days, 1-2x per year
Note: Part of Khavinson thymic complex. Can follow or precede Thymalin. Often combined with Epitalon.

Body-Weight Dosing Reference

Estimated doses extrapolated from the published research range of 1001000 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.

WeightLowTargetHigh
120 lb(54 kg)77 mcg424 mcg771 mcg
140 lb(63 kg)90 mcg495 mcg900 mcg
160 lb(73 kg)104 mcg574 mcg1043 mcg
180 lb(82 kg)117 mcg644 mcg1171 mcg
200 lb(91 kg)130 mcg715 mcg1300 mcg
220 lb(100 kg)143 mcg786 mcg1429 mcg
250 lb(113 kg)161 mcg888 mcg1614 mcg

💉 For exact syringe units based on your vial concentration, use the Thymogen Reconstitution Calculator →

Administration

Route
Sublingual tablets or subcutaneous injection
Timing
Morning.
Fasting Required?
No — food timing not critical

Expected Timeline

Day 1-10 (course)
T-cell and NK cell activity restoration begins.
Month 3-6
Sustained immune biomarker improvement with repeat courses.

Who Is It For?

Immune Senescence / T-Cell Immunity

Low

Thymic dipeptide. Restores T-cell and NK function. Khavinson protocol component.

Reconstitution Example

Vial
1 mg
Water
1 mL
Concentration
1 mg/mL
Per Unit (100u syringe)
10 mcg
Dose of 100 mcg = 10 units on a 100-unit insulin syringe

Safety & Considerations

Research peptide in Western markets. Extensively used in Russian clinical protocols. Excellent safety profile across decades of use in elderly populations.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Interactions & Contraindications

Well tolerated. Intranasal spray form is OTC in Russia — excellent safety profile. Avoid in autoimmune conditions. Standard course: 3-10 days. Can be combined with conventional antibiotics/antivirals for infection management.

Synergies & Common Stacks

Thymogen (mild thymic dipeptide, OTC) can serve as maintenance therapy between Thymosin Alpha-1 cycles (more potent, prescription-level) — graduated immune support.

Thymogen stimulates thymulin production from thymic epithelial cells — the two peptides are mechanistically linked, with Thymogen acting upstream to enhance endogenous thymulin secretion.

Dosing Quick Reference

Thymogen— Dosing Guide
Dose Range
100-1000 mcg/day (intranasal or SC)
Half-Life
~20-30 minutes
Frequency
1× daily for 3-10 days
Route
Subcutaneous
1 mg vial5 mg vial
💧 1 mL BAC water📐 1 mg/mL concentration💉 10 mcg/unit (100u syringe)
Immune & Thymiccalcmypeptide.com

Frequently Asked Questions

How does Thymogen differ from Thymalin?
Thymalin is a polypeptide thymus extract; Thymogen is a specific synthetic dipeptide (Glu-Trp). Thymogen targets thymic immune axis via known dipeptide sequence. Both are part of the Khavinson immune bioregulator toolkit.

References

  1. Khavinson VKh et al. "Thymic dipeptide Thymogen modulates neuroendocrine and immune function".” Bulletin of Experimental Biology and Medicine (1997). PMID: 9364573

📚 Related Articles

Recommended SourceOral Bioregulator

Get Thymogen from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.

Affiliate link · Full review